Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.
Trends in molecular medicine April 1, 2024 Trevor Steward
Neuroimaging combined with peripheral endocrine measures can reveal the neurobiological drivers of eating disorders such as anorexia nervosa, bulimia nervosa, and binge eating disorder. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as promising avenues for future investigation into the underlying mechanisms and potential treatments.